News

AddToAny

Google+ Facebook Twitter Twitter

Histopathology qualification funding

The IBMS has announced new funding support for Institute members undertaking IBMS/RCPath histopathology qualifications.

The IBMS has announced new funding support for Institute members undertaking IBMS/RCPath histopathology qualifications.

The funding will have a direct and positive impact on IBMS members who are currently enrolled, or about to enrol, via the pathology network route, to undertake our exams programme.

It also demonstrates a tremendous mark of confidence in the Institute’s professional examinations and underlines their value in the training of scientists to undertake advanced and consultant roles.

IBMS President, Allan Wilson, said: “This funding initiative is fantastic news for both scientists and patients moving forward.

“Histopathology laboratories have been under considerable pressure as demand for services increases.

“The funding will not only help to allay these pressures and give members the opportunity to undertake these new advanced roles, but also allow patients to reap the benefits of new developments in diagnostics, monitoring and therapy in cancer, assisting in future-proofing NHS cancer services.”  

For more information, visit bit.ly/2VEbzjv

Image Credit | iStock

Related Articles

Robotic hand with handgun aiming in wrong direction. Fatal AI error - Image credit - Shutterstock-2309476357

Tissue contamination distracts AI

In a new study, scientists trained three AI models to scan microscope slides of placenta tissue to detect blood vessel damage, estimate gestational age and classify macroscopic lesions.

Digital pathology cleared for use-history digital pathology-CREDIT-university of warwick

Digital pathology cleared for use

New research has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples.

Breast cancer 3D tomography-CREDIT-Science-Photo-Library-c0303374

Two decades of hHER2 testing

This year marks the 20th anniversary of Her2 breast cancer testing at the Royal Cornwall Hospital. Senior Biomedical Scientist Mary Jones looks back over the past two decades.

A molecular biologist working with a microscope in a modern scientific Laboratory, we see a computer screen in the foreground- CREDIT - istock-1390303303

Precision pathology for cancer with new ai tool

A new AI tool interprets medical images with unprecedented clarity, according to the results of a new study.

Top